Long-term lymphocytic leukemia (CLL) is actually a lymphoid malignancy characterised from the proliferation and accumulation of experienced CD5+ B cells within the blood, bone marrow and lymphoid tissues. The prognosis of CLL demands the existence of ≥five x109/L mono - clonal B cells of regular